Does VEDOLIZUMAB Cause Injection site warmth? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Injection site warmth have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.0% of all adverse event reports for VEDOLIZUMAB.
26
Reports of Injection site warmth with VEDOLIZUMAB
0.0%
of all VEDOLIZUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Injection site warmth From VEDOLIZUMAB?
Of the 26 reports, 3 (11.5%) required hospitalization.
Is Injection site warmth Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Injection site warmth?
ETANERCEPT (4,011)
ADALIMUMAB (1,275)
DUPILUMAB (889)
ENBREL (544)
IXEKIZUMAB (480)
GLATIRAMER (372)
HYDROXYPROGESTERONE CAPROATE (287)
HUMIRA (261)
NALTREXONE (231)
TIRZEPATIDE (213)
Which VEDOLIZUMAB Alternatives Have Lower Injection site warmth Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB